Kyowa Kirin Assigns Bone Metabolism Specialists to Promote Crysvita in Japan

Yoshihiro Furuya, SVP, Kyowa Kirin International (left) and Tadashi Yamaguchi, Director, Marketing Department, Sales & Marketing Division, Kyowa Kirin In a bid to prop up sales of its rickets drug Crysvita (burosumab) in Japan, Kyowa Kirin has appointed personnel specializing...read more